Product Program year 2025 Source: CMS Open Payments

Yutrepia

Drug Pulmonary

NDC 72964-011-01

Open in the dashboard

General payments

$36,256

476 payments

Research payments

$58,113

38 payments

Through program year 2025, $36,256 in general payments and $58,113 in research payments were reported against Yutrepia (Pulmonary).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

2 rows
Year Kind Amount Payments
2025 General $36,256 476
2025 Research $58,113 38

Breakdown

Who paid General payments · program year 2025
  1. Liquidia Technologies, Inc. $36,256 476 payments
Top recipients General payments · program year 2025
  1. Edwin Parsley Critical Care Medicine · Houston, TX $22,734 63% · 5 payments
  2. Richard Channick Critical Care Medicine · Boston, MA $302 <1% · 6 payments
  3. Rajan Saggar Pulmonary Disease · Los Angeles, CA $302 <1% · 6 payments
  4. Vallerie McLaughlin Cardiovascular Disease · Ann Arbor, MI $280 <1% · 2 payments
  5. Sandeep Sahay Pulmonary Disease · Houston, TX $253 <1% · 5 payments

The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2025.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2025
  1. Critical Care Medicine Internal Medicine $24,413 68% · 31 practitioners
  2. Pulmonary Disease Internal Medicine $5,341 15% · 163 practitioners
  3. Nurse Practitioner, Family Nurse Practitioner $1,726 5% · 64 practitioners
  4. Nurse Practitioner $960 3% · 40 practitioners
  5. Cardiovascular Disease Internal Medicine $872 2% · 19 practitioners

The top 5 of 24 specialties; each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.

The top 25 specialties, free in the app

Where the money went General payments · program year 2025
  1. Texas $23,922 66% · 33 recipients
  2. Florida $1,656 5% · 61 recipients
  3. California $1,584 4% · 37 recipients
  4. Pennsylvania $722 2% · 11 recipients
  5. Louisiana $611 2% · 23 recipients

The top 5 of 35 states; each share is of general payments naming this product in 2025 where a state was reported.

The top 25 states, free in the app

476 general · 38 research

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2025

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record